Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for New York by County

Pancreas (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


New York3


US (SEER+NPCR)1


Ulster County7


Madison County7


Tioga County7


Livingston County7


Chautauqua County7


Putnam County7


New York County7


Fulton County7


Delaware County7


Ontario County7


Bronx County7


Warren County7


Dutchess County7


Greene County7


Saratoga County7


Cayuga County7


Cattaraugus County7


Oneida County7


Jefferson County7


Westchester County7


Tompkins County7


Onondaga County7


Kings County7


Queens County7


Orange County7


Niagara County7


Genesee County7


Chemung County7


Otsego County7


Wayne County7


Clinton County7


Washington County7


Steuben County7


Monroe County7


Richmond County7


Erie County7


Columbia County7


St. Lawrence County7


Rensselaer County7


Albany County7


Rockland County7


Nassau County7


Herkimer County7


Suffolk County7


Seneca County7


Broome County7


Schenectady County7


Oswego County7


Wyoming County7


Schoharie County7


Sullivan County7


Orleans County7


Montgomery County7


Allegany County7 Chenango County7 Cortland County7 Essex County7 Franklin County7 Hamilton County7 Lewis County7 Schuyler County7 Yates County7

Notes:
Created by statecancerprofiles.cancer.gov on 10/02/2023 8:02 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
3 Source: SEER November 2022 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
7 Source: SEER November 2022 submission.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.